Company profile for AdvanCell

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AdvanCell is a radiopharmaceutical company developing next-generation cancer treatments AdvanCell’s targeted alpha therapies are powered by a platform technology – a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy – the reliable and scalable supply of isotope.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Level 7, Macquarie House, 167 Macquarie Street, Sydney, NSW, 2000
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251117627738/en/AdvanCell-Appoints-Philina-Lee-PhD-as-Chief-Executive-Officer-to-Lead-US-Expansion-and-Drive-Global-Growth

BUSINESSWIRE
17 Nov 2025

https://www.businesswire.com/news/home/20251111303258/en/AdvanCell-to-participate-in-Jefferies-Global-Healthcare-Conference-in-London

BUSINESSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/10/18/3168943/0/en/AdvanCell-s-212Pb-ADVC001-demonstrates-encouraging-safety-and-compelling-anti-tumor-activity-in-Phase-1b-in-prostate-cancer.html

GLOBENEWSWIRE
18 Oct 2025
Advancell Names Andrew Kay Chair Of Board
Advancell Names Andrew Kay Chair Of Board

16 Oct 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/10/16/3167621/0/en/AdvanCell-appoints-experienced-biotech-and-pharma-leader-Andrew-Kay-as-Chair-of-the-Board-of-Directors.html

GLOBENEWSWIRE
16 Oct 2025

https://www.globenewswire.com/news-release/2025/10/12/3165247/0/en/AdvanCell-to-present-promising-clinical-trial-results-of-ADVC001-a-novel-Lead-212-based-PSMA-targeted-alpha-therapy-for-prostate-cancer-at-ESMO-2025.html

GLOBENEWSWIRE
12 Oct 2025

https://www.globenewswire.com/news-release/2025/09/29/3157567/0/en/AdvanCell-to-Highlight-the-Potential-of-Pb-212-based-Targeted-Alpha-Therapies-for-Cancer-at-EANM-25.html

GLOBENEWSWIRE
29 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty